COVID-19 tied to approximately doubled in-hospital mortality rates versus bacterial or other viral pneumonias
Inhaled Nitric Oxide May Ease Severe COVID-19 Pneumonia in Pregnant Women
High-dose inhaled nitric oxide linked to more days free from oxygen supplementation, shorter ICU and hospital length of stay
COVID-19 Pneumonia Hospitalization Tied to New-Onset Dementia
Rate significantly higher than seen with other pneumonias
Current Guidelines May Lead to Antibiotic Overuse for SARS-CoV-2 Pneumonia
Bacterial superinfection at time of intubation occurred in <25 percent of patients; reduced antibiotic use seen with bronchoalveolar lavage-based management versus current guidelines
ATS Guideline Addresses Testing for Viral Pathogens in CAP
Nucleic acid-based testing for noninfluenza pathogens suggested for hospitalized patients who have severe CAP or are immunocompromised
Mortality, Readmission Low With COVID-19 Discharge on Home Oxygen
All-cause mortality rate 1.3 percent; 30-day readmission rate 8.5 percent among 621 patients discharged on home oxygen
Rates of Macrolide Resistance in S. pneumoniae High Across the U.S.
Clinicians should consider alternatives to macrolide monotherapy as empiric therapy for suspected community-acquired bacterial pneumonia
Short-Course Antibiotics Noninferior for Pediatric Pneumonia
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia
Cadmium Burden Linked to Mortality From Flu, Pneumonia
Risk for related mortality increased with urinary cadmium in the 80th versus the 20th percentile in whole population, never smokers in NHANES-III
Tocilizumab Cuts Progression to Ventilation or Death in COVID-19
But death from any cause by day 28 in those hospitalized with COVID-19 pneumonia did not differ for tocilizumab versus placebo
- Page 1 of 2
- 1
- 2